Search Results - collin+broholm

2 Results Sort By:
A Device for Magnetic Stimulation of the Vestibular System
Unmet NeedVestibular disorders (dizziness, vertigo, imbalance) are ubiquitous problems in clinical medicine. They account for many millions of visits to physicians and therapists every year, and often produce prolonged physical and psychological disability leading to a loss of economic productivity and a high risk of falls and injuries. Like many other...
Published: 7/4/2024   |   Inventor(s): Daniel Reich, Collin Broholm, David Zee, Dale Roberts, Michael Schubert, Jorge Otero-Millan, Bryan Ward
Keywords(s): Disease Indication, Ear and Hearing Disorders, Hearing Disorders, Other, Therapeutic Devices, Therapeutics
Category(s): Clinical and Disease Specializations, Technology Classifications > Medical Devices > Therapeutic Devices, Clinical and Disease Specializations > Ear, Nose & Throat, Technology Classifications > Medical Devices, Clinical and Disease Specializations > Ear, Nose & Throat > Hearing Disorders
A p105-based NF-(kappa) B Super repressor
C04290: A p105-based NF-(kappa) B Super repressor Technical Details: Nuclear factor (NF)-kB is a family of transcription factors that regulate immune and inflammatory responses, programmed cell death (apoptosis), and developmental processes. In normal cells, NF-kB is latent, and is activated transiently by stimuli and stresses. However, under pathological...
Published: 7/4/2024   |   Inventor(s): Li Lin
Keywords(s): Biologics, Cancers, Chemotherapy, Disease Indication, Nucleic Acid, Single, Skin Cancer, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Dermatology, Clinical and Disease Specializations > Oncology > Skin Cancer, Technology Classifications > Therapeutic Modalities > Gene Therapies, Technology Classifications > Therapeutic Modalities > Proteins, Technology Classifications > Therapeutic Modalities > Targets, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum